Affimed and NKMax America to Study the Combination of AFM24, an EGFR-Targeted Innate Cell Engager, with SNK01 Natural Killer Cell Therapy

Ads

You May Also Like

News Release: Essilor to allocate exceptional French tax refund to the Group’s initiatives to eradicate poor vision

                                                                               Essilor to allocate exceptional French tax refund to the Group's initiatives to eradicate ...